Clinical Trial Update: A Light Exposure Tracker Designed to Improve Circadian Rhythms - Aim 1 [NA]

View source ↗

Summary

Completed clinical trial evaluating a light exposure tracker designed to improve circadian rhythms in individuals with Alzheimer's disease and mild cognitive im…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Alzheimer's Disease, Mild Cognitive Impairment | NA | Status: COMPLETED